RESULTS: Of 815 patients, 70 (8.7%) had retained gastric contents on endoscopy of whom 65 (93%) had type 2 diabetes mellitus
Chng ti mang li cho khch hng cc quyn li khi mua hng: Vua Hng Hiu cam kt lun ng hnh v h tr bn trong mi kha cnh ca tri nghim mua sm, bn c th t tin v thoi mi khi mua sn phm trn Vua Hng Hiu
GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances
Integrating behavioral interventions and coordinated care models seems crucial to maximizing the clinical impact and cost-effectiveness of these medications, particularly within diverse patient populations
Semaglutide GLP-1 injections are typically used to treat medical conditions such as type 2 diabetes and obesity
In 2015, Papakyriakou et al